: Allergen immunotherapy sales in Italy experienced a sharp decline between 2008 and 2016, followed by a more gradual decrease through 2023. Differences in reimbursement, along with structural, educational, and regulatory factors, likely contributed to the decline, and warrant further research.
The Drop of Allergen Immunotherapy for Respiratory Allergy in Italy: An Assessment of Sales
Brussino, Luisa;Heffler, Enrico;Paoletti, Giovanni;
2026-01-01
Abstract
: Allergen immunotherapy sales in Italy experienced a sharp decline between 2008 and 2016, followed by a more gradual decrease through 2023. Differences in reimbursement, along with structural, educational, and regulatory factors, likely contributed to the decline, and warrant further research.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
The Drop of Allergen Immunotherapy for RespiratoryAllergy in Italy.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
796.68 kB
Formato
Adobe PDF
|
796.68 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
